These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6277108)

  • 1. [Production of anti-enterotoxin antiserum to Clostridium perfringens type A toxin].
    Bakulin IN; Zemlianitskaia EP; Sergeeva TI
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Oct; (10):111-2. PubMed ID: 6277108
    [No Abstract]   [Full Text] [Related]  

  • 2. Affinity chromatography purification of Clostridium perfringens enterotoxin.
    Scott VN; Duncan CL
    Infect Immun; 1975 Sep; 12(3):536-43. PubMed ID: 170205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic homogeneity of enterotoxin from different agglutinating serotypes of Clostridium perfringens.
    Niilo L
    Can J Microbiol; 1973 Apr; 19(4):521-4. PubMed ID: 4349468
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of enzyme linked immunosorbent assay (ELISA) in the quantitation of Clostridium perfringens type A enterotoxin and antienterotoxin antibodies.
    Narayan KG; Genigeorgis C; Behymer D
    Int J Zoonoses; 1983 Dec; 10(2):105-10. PubMed ID: 6327556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porcine Clostridium perfringens type A spores, enterotoxin and antibody to enterotoxin.
    Estrada Correa AE; Taylor DJ
    Vet Rec; 1989 Jun; 124(23):606-10. PubMed ID: 2547268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular antibody against Clostridium perfringens enterotoxin fails to counteract toxin-induced damage.
    Petrie HT; McDonel JL; Schlegel RA
    Cell Biol Int Rep; 1982 Jul; 6(7):705-11. PubMed ID: 6290086
    [No Abstract]   [Full Text] [Related]  

  • 7. Measurement of biological activities of purified and crude enterotoxin of Clostridium perfringens.
    Nilo L
    Infect Immun; 1975 Aug; 12(2):440-2. PubMed ID: 168155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody against Clostridium perfringens type A enterotoxin in healthy beef cattle and human populations in Brazil.
    Brant PC; Riemann HP; Franti CE; Torres-Anjel MJ
    Rev Latinoam Microbiol; 1978; 20(3):139-42. PubMed ID: 225770
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of enterotoxin purified from Clostridium perfringens type C.
    Skjelkvålé R; Duncan CL
    Infect Immun; 1975 May; 11(5):1061-8. PubMed ID: 164411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double antibody sandwich enzyme-immunoassay for Clostridium perfringens type A enterotoxin detection in stool specimens.
    Jackson SG; Yip-Chuck DA; Brodsky MH
    J Immunol Methods; 1985 Oct; 83(1):141-50. PubMed ID: 2865314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractoriness of rabbit towards Clostridium perfringens type A enterotoxin.
    Chakrabarty AK; Narayan KG
    Indian J Exp Biol; 1978 Mar; 16(3):402-3. PubMed ID: 210117
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence that a region(s) of the Clostridium perfringens enterotoxin molecule remains exposed on the external surface of the mammalian plasma membrane when the toxin is sequestered in small or large complexes.
    Kokai-Kun JF; McClane BA
    Infect Immun; 1996 Mar; 64(3):1020-5. PubMed ID: 8641752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enterotoxin formation by different toxigenic types of Clostridium perfringens.
    Skjelkvålé R; Duncan CL
    Infect Immun; 1975 Mar; 11(3):563-75. PubMed ID: 163799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody against Clostridium perfringens type A enterotoxin in human sera.
    Uemura T; Genigeorgis C; Riemann HP; Franti CE
    Infect Immun; 1974 Feb; 9(2):470-1. PubMed ID: 4361298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and characterization of monoclonal antibodies to Clostridium perfringens enterotoxin.
    Horiguchi Y; Uemura T; Kamata Y; Kozaki S; Sakaguchi G
    Infect Immun; 1986 Apr; 52(1):31-5. PubMed ID: 2870028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A survey of human serum samples for antibody against Clostridium perfringens type A enterotoxin in humans in Korea.
    Kim Y; Lee K; Ryu S
    Int J Food Microbiol; 1998 Jun; 41(3):239-41. PubMed ID: 9706792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equine grass sickness: serologic evidence of association with Clostridium perfringens type A enterotoxin.
    Ochoa R; de Velandia S
    Am J Vet Res; 1978 Jun; 39(6):1049-51. PubMed ID: 208433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of enterotoxin in Clostridium perfringens type A enteritis.
    Hauschild AH; Niilo L; Dorward WJ
    Can J Microbiol; 1971 Jul; 17(7):987-91. PubMed ID: 4328690
    [No Abstract]   [Full Text] [Related]  

  • 19. A conjugated synthetic peptide corresponding to the C-terminal region of Clostridium perfringens type A enterotoxin elicits an enterotoxin-neutralizing antibody response in mice.
    Mietzner TA; Kokai-Kun JF; Hanna PC; McClane BA
    Infect Immun; 1992 Sep; 60(9):3947-51. PubMed ID: 1500207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluid accumulation in mouse ligated intestine inoculated with Clostridium perfringens enterotoxin.
    Yamamoto K; Ohishi I; Sakaguchi G
    Appl Environ Microbiol; 1979 Feb; 37(2):181-6. PubMed ID: 219772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.